Chronic (Non-malignant) Musculoskeletal Pain
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic (Non-malignant) Musculoskeletal Pain trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic (Non-malignant) Musculoskeletal Pain trials you may qualify forIn this multicenter randomized controlled trial, the aim is to evaluate the effectiveness of a standardized treatment pathway (STP) for patients referred to fou…
The purpose of this study is to explore the perspectives of health professionals on chronic (non-malignant) musculoskeletal pain in adolescence and young adulth…
The purpose of this study is to assess the efficacy of the buprenorphine transdermal patch (Norspan® or Sovenor® transdermal patch) in patients with chronic non…
The purpose of the study is to assess the long-term safety profile of Tapentadol (CG5503) extended release (ER) at dosages ranging from 100 to 250 mg twice a da…
Open-Label, Safety Study to evaluate the long-term safety of Kadian NT (ALO-01) administered for up to 12 months.
The purpose of this study is to evaluate the effectiveness, tolerability, and safety of oxymorphone immediate release (IR) oral liquid as an analgesic in pediat…